Raymond James Targets $290 on Valero, Citing Margin Gains
Raymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
Knowing where to keep your cash savings securely is essential for peace of mind. Explore the safest options available to you.
22,893 articlesRaymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
A niche ETF that pays monthly dividends on small and mid-cap REITs is bracing for a refinancing squeeze as rates stay...
The AI-fueled rally pushes major indices higher, yet a tightening macro backdrop and tougher oversight loom as the ma...
With bond yields near change around 5%, an early-retiree case study shows how a shift in income from bonds alters the...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
A dramatic earnings miss sent EHang stocks lower, highlighting the challenges facing early-stage eVTOL developers. Th...
Mega IPOs grab headlines, but history often tells a different investing story. This article explains how spacex: hist...
Bank of America’s macro team expects the Fed to deliver three 25-basis-point hikes this year, pushing rates higher an...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Nike just released its latest earnings, and the stock moved in unexpected ways. This guide breaks down what nike afte...
Two transforming icons, Caterpillar and Walmart, are competing for a place in 2026 portfolios. The question: which tr...